MedPath

High-Intensity Exercise in Older Adults

Not Applicable
Completed
Conditions
Functional Fitness
Cognitive Abilities
Registration Number
NCT06199661
Lead Sponsor
University of California, Berkeley
Brief Summary

The goal of this interventional study was to test the high-intensity interval training called Aphasia Physical Exercise (APEX) in healthy older adults. The main questions it aimed to answer were:

1. what is the safety and feasibility of APEX?

2. what are APEX's acute physiological effects?

3. what is APEX's effects on functional fitness?

4. what is APEX's effects on cognition?

Participants underwent:

* Baseline testing session (#1) with cognitive measures only (a week before the Pre-exercise session);

* Pre-exercise session (#2) with maximum oxygen consumption and heart rate assessment, functional fitness and cognitive measures (3-7 days before the start of the exercise program);

* APEX program, two APEX classes per week for four weeks (eight classes in total);

* Post-exercise session (#3), functional fitness and cognitive measures, (0-2 days after the end of the exercise program).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Between the ages of 50 and 80
  • Ambulatory and community-dwelling
  • Able to travel to University of San Francisco for weekly exercise classes
  • No serious underlying health or neurological conditions
Exclusion Criteria
  • Inability to complete physical function assessment or inability to do a chair stand without using hands
  • Use of antidiabetic medications
  • Use of testosterone supplement or replacement
  • Clinical disorder precluding/interfering with participation or assessments (identified by Physical Activity Readiness Questionnaire (PAR-Q+)), including: unstable angina, arrhythmia, uncontrolled hypertension, end stage renal disease on hemodialysis, lower extremity amputation or paralysis, neurological conditions causing functional or pronounced cognitive impairments, active malignancy except for non-melanomatous skin cancers
  • Previous neurological history such as stroke, traumatic brain injury, multiple sclerosis, long-term pre-stroke seizures, Parkinson's, Alzheimer's, etc.
  • Unable to provide consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of Repetitions in 30-Second Chair Stand TestOnce 3-7 days before start of intervention and once 0-2 days after end of intervention

The number of sit-to-stands completed in 30 seconds on a standard 17" seat-height chair with arms folded across the chest.

Visual Search Task Reaction TimeOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Reaction time on correct trials in seconds

Forward Digit SpanOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

The length of the longest sequence of random digits that a participant can correctly recall twice.

Heart Rate4 weeks during intervention

Heart rate measured in beats per minute.

Functional Reach Test DistanceOnce 3-7 days before start of intervention and once 0-2 days after end of intervention

The distance in inches of an individual's forward reach with one arm while maintaining a standing position with feet flat on the floor at hip width.

Attendance Rate4 weeks during intervention

The number of classes attended out of eight total classes.

Timed Up-And-Go TimeOnce 3-7 days before start of intervention and once 0-2 days after end of intervention

The number of seconds for an individual to rise from a seated position, walk eight feet, turn around, and return to a seated position.

Number of Steps in 2-minute Step TestOnce 3-7 days before start of intervention and once 0-2 days after end of intervention

The number of right knee raises completed in two minutes while marching in place and raising each knee to a point midway between the patella (kneecap) and iliac crest (top hip bone).

Forward Spatial SpanOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

The length of the longest sequence of random positions that a participant can correctly recall.

Backward Spatial SpanOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

The length of the longest sequence of random positions that a participant can correctly report backward.

Go/No-Go Task HitsOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Hits are the proportion of correct responses on trials when "go" is presented.

Flanker Task Reaction TimesOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Reaction time on correct trials in seconds.

Stroop Task AccuracyOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Number of correct trials.

Stroop Task Reaction TimesOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Reaction time on correct trials in seconds.

Visual Search Task AccuracyOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Number of correct trials

Backward Digit SpanOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

The length of the longest sequence of random digits that a participant can correctly report backward twice.

Flanker Task AccuracyOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Number of correct trials.

Go/No-Go Task Reaction TimesOnce 10-14 days before start of intervention, once 3-7 days before start of intervention, and once 0-2 days after end of intervention

Reaction times are for hit trials only (correct responses when "go" is presented) in seconds.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of San Francisco

🇺🇸

San Francisco, California, United States

University of San Francisco
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.